CN109908095A — 一种西尼莫德片剂及制备方法
Assigned to Guangdong Solon Biomedical Technology Co Ltd · Expires 2019-06-21 · 7y expired
What this patent protects
本发明属于医药技术领域,具体涉及一种西尼莫德片剂及制备方法,本发明的西尼莫德片剂由西尼莫德、崩解剂、稀释剂、润滑剂、粘合剂、防潮剂及其他药学上可接受的辅料制成,西尼莫德为结晶西尼莫德,稀释剂由微晶纤维素和乳糖的混合物组成,崩解剂为羧甲基淀粉纳,润滑剂由滑石粉和二氧化硅的混合物组成,粘合剂为聚乙烯吡咯烷酮PVPK30,本发明采用干法制粒的方法,工艺步骤简单,产品生产周期短,制备得到的产品外观优良,含量和溶出度均合格。
USPTO Abstract
本发明属于医药技术领域,具体涉及一种西尼莫德片剂及制备方法,本发明的西尼莫德片剂由西尼莫德、崩解剂、稀释剂、润滑剂、粘合剂、防潮剂及其他药学上可接受的辅料制成,西尼莫德为结晶西尼莫德,稀释剂由微晶纤维素和乳糖的混合物组成,崩解剂为羧甲基淀粉纳,润滑剂由滑石粉和二氧化硅的混合物组成,粘合剂为聚乙烯吡咯烷酮PVPK30,本发明采用干法制粒的方法,工艺步骤简单,产品生产周期短,制备得到的产品外观优良,含量和溶出度均合格。
Drugs covered by this patent
- Mayzent (SIPONIMOD) · Novartis
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.